Alzheimer’s: a genetic variant associated with hippocampal volume, without evidence of causal protection

A genetic variant could help explain why hippocampal volume differs between individuals. A study links the G allele of rs7315280 to a larger hippocampus and more favorable indicators relating to Alzheimer’s disease. But these associations, supplemented by functional experiments, demonstrate neither causal protection nor the effectiveness of a treatment.

Illustration of the location of the hippocampus in the human brain.
MindsetEditorial illustration, not study data.

An association studied across several cohorts

The researchers combined genome-wide association data from UK Biobank, with 33,731 participants, and the ENIGMA consortium, with 26,814 participants. Their aim was to identify genetic variations associated with the volume of the hippocampus, whose atrophy is an important biomarker of Alzheimer’s disease.

They then examined the associations in the ADNI-1 cohort, comprising 756 participants, accounting for polygenic risk scores. In this cohort, carriers of the G allele had a larger hippocampal volume. The abstract also reports later disease onset and an association with a lower likelihood of Alzheimer’s.

However, the abstract does not provide detailed participant characteristics, follow-up duration or the comparative data needed to translate these findings into an absolute risk difference.

A biological lead involving the TESC gene

The study goes beyond statistical association. The researchers used genomic annotations, transcriptional activity assays and an analysis linking genetic variations to gene expression in the brain.

According to the abstract, rs7315280 is located in regulatory regions active in the hippocampus. The G allele increased transcriptional activity in the assays performed. The variant was also associated with TESC expression in the human prefrontal cortex.

These findings support a biological hypothesis: this variant could influence Alzheimer’s-related processes by modulating TESC expression. They do not demonstrate that this modulation alone explains the observed clinical associations.

What this discovery does not yet allow

A larger hippocampus is not, on its own, evidence of preserved cognition. Likewise, identifying a genetic region associated with the disease does not show that targeting this region or TESC would provide a therapeutic benefit.

This study therefore identifies a research lead, not an intervention to adopt. The dossier does not justify individual genetic testing, a supplement or a prevention strategy based on rs7315280.

Limitations to keep in mind

Only the PubMed abstract was consulted, not the full text. Follow-up duration, detailed participant characteristics, uncertainty intervals and several comparative details are not available in the dossier. Funding and conflicts of interest have not been verified.

What we can take away

The rs7315280 variant offers a lead for studying the links between genetic regulation, hippocampal volume and Alzheimer’s. Causal protection and therapeutic usefulness remain to be established.

Sources and provenance

Partager cet article

X f in

An error or a source to report? Contact the editorial team.